A woman reports a substantial weight loss following a minimally-invasive procedure. During an interview with Good Morning America on Thursday, May 9, Brooke Nelson disclosed that she has shed 60 pounds since engaging in a recent clinical trial, having previously tipped the scales at over 200 pounds.
"The persistent cravings for food have significantly diminished," she shared with the outlet. "While there are still occasions when I yearn for a chocolate chip cookie, I now find myself craving healthier options like greens much more frequently."
Dr. Christopher McGowan elaborated on the innovative procedure, termed endoscopic ablation, in an interview with GMA. This technique specifically targets ghrelin, commonly referred to as the "hunger hormone."
During the procedure, a camera is inserted into the patient's stomach while fluids are administered, ensuring the protection of the underlying stomach tissue.
Subsequently, a small device is utilized to cauterize the upper lining of the stomach, the site where ghrelin is synthesized. Ghrelin plays a pivotal role in transmitting hunger signals to the brain, while also modulating insulin secretion and facilitating fat storage.
McGowan, the brain behind True You Weight Loss in Cary, North Carolina, has applied his method to ten female participants thus far as part of the clinical trial.
"We have patients who have surpassed a year since their initial procedure, and what we're observing is a sustained reduction in hunger and improved control over eating," the gastroenterology specialist informed GMA. He noted that trial participants, on average, achieved a seven percent reduction in overall weight.
McGowan emphasized that the procedure offers the potential for significant weight loss without the downtime and risks associated with surgery. "For individuals hesitant about surgical intervention, this may present a more palatable option," he remarked regarding endoscopic ablation.
Nonetheless, McGowan clarified that despite its minimally-invasive nature, the procedure isn't entirely devoid of risks. "Potential risks of this technology include ulceration, bleeding, or inadvertent injury to the stomach. We took great care to mitigate these risks," he explained to GMA. "In our experience, any adverse effects were mild, encompassing symptoms such as cramping, gas, and nausea—typical post-procedural discomfort. However, there were no instances of complications."
This marks the inaugural human trial of the procedure. McGowan is slated to formally present the trial's outcomes later this month at Digestive Disease Week, a medical conference held in Washington, D.C., as reported by ABC News.
Before endoscopic ablation can be greenlit for widespread use, further testing is imperative.
The Quran - Chapter Qaf : 12 - 15
Before them, the people of Noah denied ˹the truth,˺ as did the people of the Water-pit,1 Thamûd,
’Ȃd, Pharaoh, the kinfolk of Lot,
the residents of the Forest, and the people of Tubba’. Each rejected ˹their˺ messenger, so My warning was fulfilled.
Were We incapable of creating ˹them˺ the first time? In fact, they are in doubt about ˹their˺ re-creation.
In the course of history, as presented by the Quran, it has happened again and again that as a result of the prophets’ addressees rejecting them, the communities were destroyed.
A few of these devastated nations are mentioned here by way of example. The destruction of these peoples is, in fact, a sample of the conditions in the Hereafter. A part of the punishment the rejecters of Truth are destined to receive in the Hereafter is shown here in this world of today.
The first creation of this world proves the possibility of the second creation. If a man is serious, he does not require any further proof, to make him believe in the Hereafter.
